The Beauty M&A Landscape Under Scrutiny: Waldencast’s Divestment of Obagi Medical Signals Shifting Market Dynamics

The global beauty industry, a sector historically characterized by robust mergers and acquisitions (M&A) activity, is currently navigating a period of recalibration. This week’s spotlight falls on Waldencast’s strategic decision…

Bridgepoint Group to Acquire Obagi Medical from Waldencast for $460 Million

London, UK – In a significant development within the global beauty and skincare industry, UK-based investment firm Bridgepoint has announced its agreement to acquire Obagi Medical, a prominent clinical skincare…